SMALL BUT BEAUTIFUL: Vet services group shows healthy revenue growth

DECHRA, the animal drug and veterinary services group, yesterday reported a 23 per cent jump in revenue in the six months to 31 December.
By The Newsroom
Published 12th Jan 2009, 00:00 BST

On a like-for-like basis – excluding the VetXX business, which was acquired in January 2008 – revenue was about 9.5 per cent ahead of the previous financial year.

The group said: "Trading for the financial year ending 30 June remains in line with the board's expectations." Dechra is expected to announce its interim results on 24 February.

Hide Ad
Hide Ad

The group – which has pharmaceuticals and services divisions – said the integration of VetXX had been "completed successfully", with the acquired company rebranded as Dechra Veterinary Products.

Dechra said: "We remain confident that our strategy and development pipeline have positioned the group to respond resolutely to challenging times. The group's cash flow remains strong, our banking facilities secure and balance sheet robust; we therefore remain optimistic about the group's future prospects."

The group, which has a market cap of about 260 million, includes

insurance company Vet2Pet.